Libracor

Bisoprolol fumarate, the active ingredient in Libracor, is a beta blocker presented as an oral tablet for oral use. It is employed to manage high blood pressure, chronic heart failure, and angina pectoris in adult patients.

GNH USA supplies Libracor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Libracor is a selective β1‑adrenergic blocker used in cardiovascular disease management. - Hypertension: lowers systemic blood pressure and reduces cardiovascular risk. - Chronic heart failure: improves left‑ventricular function and decreases mortality. - Angina pectoris: reduces myocardial oxygen demand and relieves chest pain.

Libracor may cause a range of adverse reactions.

Common Side Effects: - Fatigue: feeling unusually tired or weak. - Dizziness: light‑headed sensation, especially on standing. - Headache: mild to moderate pain in the head. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea or abdominal discomfort.

Serious or Rare Side Effects: - Severe bradycardia: dangerously low heart rate requiring medical attention. - Heart block: impaired electrical conduction in the heart. - Hypotension: markedly low blood pressure causing faintness. - Bronchospasm: narrowing of airways, especially in asthmatic patients. - Allergic reactions: rash, itching, or swelling. - Depression: mood changes or depressive symptoms.

Before prescribing Libracor, clinicians should consider several safety factors. - Dose adjustment in renal impairment: reduce dose as needed based on renal function. - Monitor heart rate: avoid use if resting heart rate is below 60 bpm. - Caution in asthma or COPD: may exacerbate bronchospasm. - Avoid abrupt discontinuation: taper gradually to prevent rebound hypertension. - Use with caution in diabetes: may mask hypoglycaemia symptoms. - Store at ambient temperature: keep in original container, protect from moisture and light.

Libracor can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Other beta‑blockers: additive negative‑chronotropic effects. - Non‑dihydropyridine calcium channel blockers (verapamil, diltiazem): risk of severe bradycardia. - Certain antiarrhythmics (e.g., amiodarone): increased risk of heart block.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate hypotensive effects. - ACE inhibitors or ARBs: enhanced blood pressure lowering. - NSAIDs: may reduce antihypertensive efficacy. - Antidiabetic agents: possible masking of hypoglycaemia. - Antidepressants (e.g., SSRIs): monitor for bradycardia.